Eltanexor

N/A

Report date: 2024/05/20 16:19:34
NME

Base Information

Drug NameEltanexor
Drug Alias NameATG-016KPT-8602ONO-7706
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesProstatic Neoplasms, Castration-Resistant +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesKaryopharm Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKaryopharm Therapeutics Inc
Inactive CompaniesNational Cancer InstituteAntengene Corporation (Shanghai) LtdAntengene Corporation Co Ltd
Active IndicationsMyelodysplastic SyndromesProstatic Neoplasms, Castration-ResistantRectal Neoplasms +[5] 
Inactive IndicationsSolid tumoursColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A